Review
Nicotinic acid--the underused ally in the fight against coronary disease
Affiliations
- PMID: 9475669
Item in Clipboard
Review
Nicotinic acid--the underused ally in the fight against coronary disease
J Cardiovasc Risk.
1997 Jun.
No abstract available
Comment on
-
Nicotinic acid treatment shifts the fibrinolytic balance favourably and decreases plasma fibrinogen in hypertriglyceridaemic men.J Cardiovasc Risk. 1997 Jun;4(3):165-71. J Cardiovasc Risk. 1997. PMID: 9475670 Clinical Trial.
Similar articles
-
Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.Curr Med Res Opin. 2001;17(1):60-73. Curr Med Res Opin. 2001. PMID: 11464448 Review.
-
Niaspan: new hope for heart patients.Drug Discov Today. 2005 Jan 1;10(1):4-5. doi: 10.1016/S1359-6446(04)03337-9. Drug Discov Today. 2005. PMID: 15676289 No abstract available.
-
Nicotinic acid and the prevention of coronary artery disease.Curr Opin Lipidol. 2009 Aug;20(4):321-6. doi: 10.1097/MOL.0b013e32832d3b9d. Curr Opin Lipidol. 2009. PMID: 19494772 Review.
-
Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials.J Am Coll Cardiol. 2005 Jan 18;45(2):185-97. doi: 10.1016/j.jacc.2004.10.031. J Am Coll Cardiol. 2005. PMID: 15653014
-
Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review.J Intern Med. 2005 Aug;258(2):94-114. doi: 10.1111/j.1365-2796.2005.01528.x. J Intern Med. 2005. PMID: 16018787 Review.
Cited by
-
Combination drug therapy for dyslipidemia.Curr Atheroscler Rep. 1999 Jul;1(1):44-9. doi: 10.1007/s11883-999-0049-z. Curr Atheroscler Rep. 1999. PMID: 11122691 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical